Drug Safety

Thalidomide Maker Hopes Safer Drugs Follow

Published in Cancer Weekly, September 7th, 1998

The maker of thalidomide, which has won U.S. Food and Drug Administration (FDA) approval despite being haunted by a history of terrible birth defects, said he hopes safer and more effective drugs follow soon.

The FDA approved thalidomide for use against leprosy, with the tacit acceptance that the drug would in fact be used more often in experimental therapy for a range of disease from cancer to AIDS to rheumatoid arthritis.

"We can't promote it (for these other uses), but we can sell it," said Sol Barer, of New Jersey-based Celgene Corp., which makes thalidomide under the name Thalomid. The approval makes it easier to control the drug, he said. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-09-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry